David Grinblatt to Alemtuzumab
This is a "connection" page, showing publications David Grinblatt has written about Alemtuzumab.
Connection Strength
0.240
-
Results of Cancer and Leukemia Group B 10102 (Alliance), a Phase 1/2 Study. Cancer. 2025 Feb 15; 131(4):e35750.
Score: 0.240
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.